Tower Cancer Research Foundation is honored to name its Clinical Trials Program in tribute to Frank E. Rosenfelt, an individual who played an important role in its establishment. Frank Rosenfelt was an entertainment attorney, first at RKO, and later rising through the ranks of MGM to become general counsel and eventually president and CEO in 1972. His ten years as studio chief were exceedingly successful, and after leaving MGM he continued to work elsewhere in prestigious positions.
He developed close friendships with a large number of important individuals in the industry, who held him in very high regard. As a result of this network and the Rosenfelt family’s deep commitment to cancer research, significant philanthropic contributions have been made to TCRF. We are grateful for this support which has enabled the Foundation to double its clinical trials activity in just the past two years. |
|